Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
December 22, 2003
- DIAGNOSTIC NEWS IN BRIEF
December 22, 2003
- Dainippon Sees 3 New Drugs as Potential Blockbusters
December 22, 2003
- Semi-annual Business Results
December 22, 2003
- Atol: Sales, Profits Down
December 15, 2003
- Yomeishu: Sales Slip 5.4%
December 15, 2003
- Ohki: Consolidated Sales Grow 8.2%
December 15, 2003
- OTC NEWS IN BRIEF
December 15, 2003
- Ando Chemical Works: Sales Down 8.2% to \12.4 Bil.
December 15, 2003
- GSK Completes PI Study on Ono's New HIV Drug in the US
December 15, 2003
- Nippon Chemiphar: Drug Sales Fall 9.9% to \7,738 Mil.
December 15, 2003
- AnGes MG Begins PIII Study on HGF Gene Therapy Drug
December 15, 2003
- Teikoku Hormone: Sales, Profits Declines
December 15, 2003
- Osaka Univ. Venture iCAT to Develop Implant Treatment System
December 15, 2003
- ON THE MOVW
December 15, 2003
- Dr Shirakawa Wins Baelz Prize for 2003
December 15, 2003
- Rohto: Added-value Products, Overseas Growth Boost Sales
December 15, 2003
- Press Seminar
December 15, 2003
- NHI Price Listing Approved for 11 Drugs Including Pediatric Protopic Ointment, BI・Sifrol
December 15, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
December 15, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…